Binding and endocytosis of heparin by human endothelial cells in culture
- PMID: 3995089
- DOI: 10.1016/0167-4889(85)90177-6
Binding and endocytosis of heparin by human endothelial cells in culture
Abstract
Binding of heparin and low molecular weight heparin fragments (CY 222, Mr range 1500-8000) to human vascular endothelial cells was studied. Primary culture of human umbilical vein endothelial cells and either 125I or 3H-labeled heparin or [125I]CY 222 were used. Slow, saturable and specific binding was found. No other tested glycosaminoglycan, excepting a highly sulfated heparan fraction, was able to compete for heparin binding. Two groups of binding sites for [3H]heparin could be distinguished: one with high affinity (Kd = 0.12 microM) and another with lower affinity (Kd = 1.37 microM) and a relative large capacity of binding (1.16 X 10(7) molecules/cell) was calculated. The Kd for unlabeled heparin, as calculated from competition experiments, was 0.23 microM. Much lower affinity was calculated for unlabeled low molecular weight heparin fragments CY 222 (Kd = 4.3 microM) from competition experiments with [125I]CY 222. The binding reversibility was only partial for unfractionated heparin. Even by chasing with unlabeled compound, a fraction of 25-30% was not dissociable from endothelial cells. This fraction was much lower if incubation was carried out at 4 degrees C. The addition of basic proteins (histones) to the incubation medium greatly enhanced the undissociable binding at 37 degrees C, but not at 4 degrees C. The undissociable fraction of heparin was not available to degradation by purified microbial heparinase. These results suggest that a fraction of bound heparin is internalized by the vascular endothelium.
Similar articles
-
Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture.Nouv Rev Fr Hematol (1978). 1984;26(4):243-7. Nouv Rev Fr Hematol (1978). 1984. PMID: 6473094
-
Affinity of binding of radiolabeled (125I) heparin and low molecular weight heparin fraction CY 222 to endothelium in culture.Folia Haematol Int Mag Klin Morphol Blutforsch. 1987;114(3):429-36. Folia Haematol Int Mag Klin Morphol Blutforsch. 1987. PMID: 2444518
-
Expression of externally-disposed heparin/heparan sulfate binding sites by uterine epithelial cells.J Cell Physiol. 1990 Apr;143(1):60-7. doi: 10.1002/jcp.1041430108. J Cell Physiol. 1990. PMID: 2138625
-
Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells.Thromb Res. 1988 Feb 15;49(4):373-83. doi: 10.1016/0049-3848(88)90240-x. Thromb Res. 1988. PMID: 2837834
-
Binding of low molecular weight heparin (Tinzaparin sodium) to bovine endothelial cells in vitro.Thromb Res. 1994 Jul 15;75(2):185-94. doi: 10.1016/0049-3848(94)90067-1. Thromb Res. 1994. PMID: 7974392
Cited by
-
Endothelial binding sites for heparin. Specificity and role in heparin neutralization.Biochem J. 1986 Sep 15;238(3):847-54. doi: 10.1042/bj2380847. Biochem J. 1986. PMID: 2432885 Free PMC article.
-
Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.Drugs. 1990 Oct;40(4):498-530. doi: 10.2165/00003495-199040040-00003. Drugs. 1990. PMID: 1964634 Review.
-
Revisiting the Pharmacology of Unfractionated Heparin.Clin Pharmacokinet. 2019 Aug;58(8):1015-1028. doi: 10.1007/s40262-019-00751-7. Clin Pharmacokinet. 2019. PMID: 30850987 Review.
-
Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia.Infect Immun. 1995 Sep;63(9):3520-6. doi: 10.1128/iai.63.9.3520-3526.1995. Infect Immun. 1995. PMID: 7642286 Free PMC article.
-
Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation.Pulm Pharmacol Ther. 2013 Apr;26(2):296-304. doi: 10.1016/j.pupt.2012.12.009. Epub 2012 Dec 29. Pulm Pharmacol Ther. 2013. PMID: 23280431 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical